Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.